Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.
2.

[Treatment of Wegener's granulomatosis].

Riccieri V, Valesini G.

Reumatismo. 2004 Apr-Jun;56(2):69-76. Review. Italian.

3.

Wegener's granulomatosis and ANCA syndromes.

Jaffe IA.

Neurol Clin. 1997 Nov;15(4):887-91. Review.

PMID:
9367970
4.

Update on the treatment of Wegener's granulomatosis.

Esper GJ, Johnson JS.

Bull Rheum Dis. 1999;48(11):1-4. Review.

PMID:
10721552
5.

[Wegener's granulomatosis and microscopic polyangiitis].

Pagnoux C.

Rev Prat. 2008 Mar 15;58(5):522-32. Review. French.

PMID:
18524109
6.

Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis.

Langford CA.

Clin Exp Immunol. 2011 May;164 Suppl 1:31-4. doi: 10.1111/j.1365-2249.2011.04364.x. Review.

7.

Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Fauci AS, Haynes BF, Katz P, Wolff SM.

Ann Intern Med. 1983 Jan;98(1):76-85. Review.

PMID:
6336643
8.

[Wegener's granulomatosis in ENT: clinical presentation, diagnosis and therapy].

Tesche S, Münscher A, Metternich FU.

Laryngorhinootologie. 2007 Nov;86(11):775-9. Epub 2007 Aug 27. Review. German.

PMID:
17724622
9.

Wegener's granulomatosis.

Harman LE, Margo CE.

Surv Ophthalmol. 1998 Mar-Apr;42(5):458-80. Review.

PMID:
9548575
10.

Pituitary involvement in Wegener's granulomatosis.

Yong TY, Li JY, Amato L, Mahadevan K, Phillips PJ, Coates PS, Coates PT.

Pituitary. 2008;11(1):77-84. Review.

PMID:
17492510
11.

Treatment of Wegener's granulomatosis.

Regan MJ, Hellmann DB, Stone JH.

Rheum Dis Clin North Am. 2001 Nov;27(4):863-86, viii. Review.

PMID:
11723769
12.

Advances in the therapy of Wegener's granulomatosis.

Hellmich B, Lamprecht P, Gross WL.

Curr Opin Rheumatol. 2006 Jan;18(1):25-32. Review.

PMID:
16344616
13.

Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.

Lee RW, D'Cruz DP.

Drugs. 2008;68(6):747-70. Review.

PMID:
18416584
14.

Cutaneous Wegener's granulomatosis: a variant or atypical localized form?

Kuchel J, Lee S.

Australas J Dermatol. 2003 May;44(2):129-35. Review.

PMID:
12752188
15.

Pharmacological therapy for Wegener's granulomatosis.

White ES, Lynch JP.

Drugs. 2006;66(9):1209-28. Review.

16.

Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.

Knight A, Askling J, Granath F, Sparen P, Ekbom A.

Ann Rheum Dis. 2004 Oct;63(10):1307-11. Epub 2004 May 6. Review.

17.

Wegener's granulomatosis.

Lamprecht P, Gross WL.

Herz. 2004 Feb;29(1):47-56. Review.

PMID:
14968341
18.

Therapeutics of Wegener's granulomatosis.

Wung PK, Stone JH.

Nat Clin Pract Rheumatol. 2006 Apr;2(4):192-200. Review.

PMID:
16932685
19.

Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis.

Solans-Laqué R, Bosch-Gil J, Canela M, Lorente J, Pallisa E, Vilardell-Tarrés M.

Lupus. 2008 Sep;17(9):832-6. doi: 10.1177/0961203308089693. Review.

PMID:
18755865
20.

Prolonged treatment with low-dose intravenous pulse cyclophosphamide may reduce rate of relapse in ANCA-associated vasculitis.

Dhaygude A, Griffith M, Cairns T, McLean A, Palmer A, Taube D.

Nephron Clin Pract. 2004;97(4):c154-9. Review.

PMID:
15331939

Supplemental Content

Support Center